Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
424studies shown
Showing 301-312 of 424
Drug study icon
RecruitingNCT04366518

Toward a Computationally-Informed, Personalized Treatment for Hallucinations

This summary needs review. Please check the official study record and contact the research team for details.

In New Haven
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States
Sponsor
Yale University
Condition
Schizophrenia
Other study type icon
RecruitingNCT06743711

Validation and Impact of Cardiorespiratory Fitness in Severe Mental Illness - the Heart in Mind Project

This summary needs review. Please check the official study record and contact the research team for details.

In Glostrup Municipality
Why is this study shown?

This study is directly about Schizophrenia.

Schizophrenia, BipolarityObservationalA study where researchers collect information without assigning a treatment.From 18 Years to 45 Years
Countries
Denmark
Sponsor
Bjorn H. Ebdrup
Condition
Schizophrenia, Bipolarity
Drug study icon
RecruitingNCT05590637

Comparing Antipsychotic Medications in LBD Over Time

This summary needs review. Please check the official study record and contact the research team for details.

In San Antonio
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrug
Countries
United States
Sponsor
The University of Texas Health Science Center at San Antonio
Condition
Schizophrenia
Other study type icon
RecruitingNCT06958341

Neuroimmunology Registry and Biobank

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Berlin
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservational
Countries
Germany
Sponsor
Charite University, Berlin, Germany
Condition
Schizophrenia
Drug study icon
RecruitingNCT04478838

"Extended" (Alternate Day) Antipsychotic Dosing

This summary needs review. Please check the official study record and contact the research team for details.

In Toronto
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugOver 18 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Schizophrenia
Drug study icon
RecruitingNCT07369154

52-week Open Label Safety-Tolerability Study

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Chandler
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
LB Pharmaceuticals Inc.
Condition
Schizophrenia
Drug study icon
RecruitingNCT07615426

Aticaprant for schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States.

Multiple locations, including Garden Grove
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Janssen Research & Development, LLC
Condition
Schizophrenia
Other study type icon
RecruitingNCT06657430

A Study on the Preference of Risperidone Dosage Forms

This summary needs review. Please check the official study record and contact the research team for details.

In Shanghai
Why is this study shown?

This study is directly about Schizophrenia.

Schizophrenia, BipolarityObservationalOver 18 Years
Countries
China
Sponsor
Shanghai Mental Health Center
Condition
Schizophrenia, Bipolarity
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.